Thx imback- smaller less expensive trial to get the label expanded to adults.
I think it was @omnisearch who came up with total patient numbers under 70?
Smaller trial costing less and presumably a much shorter time to recruit fits with not proceeding at this time.
Still, spending ten million of available cash indicates supreme confidence.
My personal opinion
Reg
2024 Here we go again., page-588
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.14 |
Change
0.003(0.22%) |
Mkt cap ! $1.307B | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.17 | $1.14 | $2.768M | 2.402M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 111823 | $1.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.15 | 43063 | 5 |
View Market Depth
| Last trade - 10.46am 19/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |